Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q2 2026

Agentix Q2 2026 Results: Net Loss of $91K, Loss Narrows

Agentix Corp. reported a net loss of $208,699 for the six months ended September 30, 2026, compared to a loss of $329,931 in the prior year period. The company continues to operate as a clinical-stage biotechnology firm with significant liquidity concerns, reporting only $1,312 in cash and an accumulated deficit of over $7.2 million.

Q2 2026 at a glance · $ million
MetricQ2 2026Q2 2025
Profit before tax-0.1-0.1
Net income-0.1-0.1
EPS (diluted, $ a share)$-0.00$-0.00

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC, OTC: AGTX. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Agentix Corp.: key numbers

Share price
$0.0337Close, Nov 13
Market cap
$1.35M
Shares outstanding
40.07MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers, updated daily. Not a valuation or a recommendation.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.